Aptus Capital Advisors, LLC Ark Genomic Revolution ETF (De Transaction History
Aptus Capital Advisors, LLC
- $8.97 Billion
- Q1 2025
A detailed history of Aptus Capital Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 3,447 shares of ARKG stock, worth $75,385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,447
Previous 487
607.8%
Holding current value
$75,385
Previous $11,000
545.45%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ARKG
# of Institutions
278Shares Held
20.9MCall Options Held
4.66MPut Options Held
3.85M-
Jpmorgan Chase & CO New York, NY3.43MShares$75.1 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.29MShares$71.9 Million0.01% of portfolio
-
Citigroup Inc2.56MShares$56 Million0.03% of portfolio
-
Morgan Stanley New York, NY2.37MShares$51.7 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.2MShares$26.4 Million0.0% of portfolio